Skip to content

H.R. 1518 · 119th Congress (2025–2027)

New Era of Preventing End-Stage Kidney Disease Act

This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease.

Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute.

The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations.

Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease.

Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.

Show official title

To amend the Public Health Service Act with respect to preventing end-stage kidney disease, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1518’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Gus M. Bilirakis (R-FL-12)
Cosponsors
64 cosponsors

7 original · 57 later

19 R · 45 D

  1. Rep. Troy Balderson (R-OH-12)· Original · Feb 24, 2025
  2. Rep. Danny K. Davis (D-IL-7)· Original · Feb 24, 2025
  3. Rep. Carol D. Miller (R-WV-1)· Original · Feb 24, 2025
  4. Rep. Scott H. Peters (D-CA-50)· Original · Feb 24, 2025
  5. Rep. Terri A. Sewell (D-AL-7)· Original · Feb 24, 2025
  6. Rep. Bradley Scott Schneider (D-IL-10)· Original · Feb 24, 2025
  7. Rep. Paul Tonko (D-NY-20)· Original · Feb 24, 2025
  8. Rep. Ted Lieu (D-CA-36)· Later · Mar 3, 2025
  9. Rep. Neal P. Dunn (R-FL-2)· Later · Mar 10, 2025
  10. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Mar 11, 2025
  11. Rep. Dan Crenshaw (R-TX-2)· Later · Mar 14, 2025
  12. Del. Eleanor Holmes Norton (D-DC)· Later · May 7, 2025
  13. Rep. Thomas R. Suozzi (D-NY-3)· Later · May 14, 2025
  14. Rep. Julia Brownley (D-CA-26)· Later · May 19, 2025
  15. Rep. Michael Lawler (R-NY-17)· Later · May 19, 2025
  16. Rep. Jay Obernolte (R-CA-23)· Later · May 19, 2025
  17. Rep. Kathy Castor (D-FL-14)· Later · Jun 3, 2025
  18. Rep. Donald G. Davis (D-NC-1)· Later · Jun 6, 2025
  19. Rep. Joe Wilson (R-SC-2)· Later · Jun 23, 2025
  20. Rep. Rashida Tlaib (D-MI-12)· Later · Jun 30, 2025
  21. Rep. Henry C. "Hank" Johnson, Jr. (D-GA-4)· Later · Jul 23, 2025
  22. Rep. Patrick Ryan (D-NY-18)· Later · Jul 23, 2025
  23. Rep. Sanford D. Bishop, Jr. (D-GA-2)· Later · Jul 25, 2025
  24. Rep. Andrew R. Garbarino (R-NY-2)· Later · Jul 25, 2025
  25. Rep. Jerrold Nadler (D-NY-12)· Later · Jul 25, 2025
  26. Rep. J. Luis Correa (D-CA-46)· Later · Jul 29, 2025
  27. Rep. James P. McGovern (D-MA-2)· Later · Jul 29, 2025
  28. Rep. Jonathan L. Jackson (D-IL-1)· Later · Aug 1, 2025
  29. Rep. Jason Crow (D-CO-6)· Later · Aug 5, 2025
  30. Rep. Al Green (D-TX-9)· Later · Aug 12, 2025
  31. Rep. Zoe Lofgren (D-CA-18)· Later · Aug 12, 2025
  32. Rep. Deborah K. Ross (D-NC-2)· Later · Aug 12, 2025
  33. Rep. Darren Soto (D-FL-9)· Later · Aug 12, 2025
  34. Rep. Robert Menendez (D-NJ-8)· Later · Aug 19, 2025
  35. Rep. Sarah McBride (D-DE)· Later · Aug 26, 2025
  36. Rep. Young Kim (R-CA-40)· Later · Sep 3, 2025
  37. Rep. Alexandria Ocasio-Cortez (D-NY-14)· Later · Sep 3, 2025
  38. Rep. Eugene Simon Vindman (D-VA-7)· Later · Sep 3, 2025
  39. Rep. Glenn Ivey (D-MD-4)· Later · Sep 30, 2025
  40. Rep. Jefferson Van Drew (R-NJ-2)· Later · Sep 30, 2025
  41. Rep. Mike Carey (R-OH-15)· Later · Oct 21, 2025
  42. Rep. Haley M. Stevens (D-MI-11)· Later · Oct 21, 2025
  43. Rep. Henry Cuellar (D-TX-28)· Later · Nov 4, 2025
  44. Rep. Mike Flood (R-NE-1)· Later · Nov 4, 2025
  45. Rep. Gabe Vasquez (D-NM-2)· Later · Dec 17, 2025
  46. Rep. Jennifer A. Kiggans (R-VA-2)· Later · Feb 26, 2026
  47. Rep. Susie Lee (D-NV-3)· Later · Feb 26, 2026
  48. Rep. Janelle S. Bynum (D-OR-5)· Later · Apr 6, 2026
  49. Rep. Yvette D. Clarke (D-NY-9)· Later · Apr 6, 2026
  50. Rep. Judy Chu (D-CA-28)· Later · Apr 6, 2026
  51. Rep. Veronica Escobar (D-TX-16)· Later · Apr 6, 2026
  52. Rep. Mike Levin (D-CA-49)· Later · Apr 6, 2026
  53. Rep. Mark Pocan (D-WI-2)· Later · Apr 6, 2026
  54. Rep. Bennie G. Thompson (D-MS-2)· Later · Apr 6, 2026
  55. Rep. Mike Thompson (D-CA-4)· Later · Apr 20, 2026
  56. Rep. James R. Walkinshaw (D-VA-11)· Later · Apr 22, 2026
  57. Rep. Jack Bergman (R-MI-1)· Later · Jul 27, 2026
  58. Rep. Abraham J. Hamadeh (R-AZ-8)· Later · Jul 27, 2026
  59. Rep. William R. Keating (D-MA-9)· Later · Aug 13, 2026
  60. Rep. Don Bacon (R-NE-2)· Later · Aug 20, 2026
  61. Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Later · Aug 20, 2026
  62. Rep. Gwen Moore (D-WI-4)· Later · Oct 5, 2026
  63. Rep. Chellie Pingree (D-ME-1)· Later · Oct 9, 2026
  64. Rep. Christopher H. Smith (R-NJ-4)· Later · Oct 15, 2026
Policy area
Health
Subjects
  • Congressional oversight
  • Digestive and metabolic diseases
  • Genetics
  • Government studies and investigations
  • Health care coverage and access
  • Health programs administration and funding
  • Health promotion and preventive care
  • Medical education
  • 3 more
    • Medical research
    • Medical tests and diagnostic methods
    • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 24, 2025
  2. HouseWays and MeansReferred Feb 24, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. New Era of Preventing End-Stage Kidney Disease Act

    Display title, Short title · Introduced in House

  2. To amend the Public Health Service Act with respect to preventing end-stage kidney disease, and for other purposes.

    Official title · Introduced in House